Skip to main content
. 2017 Jun 28;8(38):63187–63207. doi: 10.18632/oncotarget.18730

Table 1. Combination study of BIX-01294 and SAHA.

Inhibitor (10 μM) MDA-MB-231 MCF-7
SAHA 2.874±0.84 8.124±4.98
BIX-01294 2.155±0.88 8.103±1.99
SAHA+BIX-01294 1.891±0.56 8.564±2.17